Creation of a Probabilistic Atlas of Normal Cerebral Uptake of 18F-FDG in PET/MRI.
- Conditions
- Brain Diseases
- Interventions
- Diagnostic Test: brain PET-MRI with 18F-FDG
- Registration Number
- NCT05355857
- Lead Sponsor
- Institut de cancérologie Strasbourg Europe
- Brief Summary
With 18F-FDG PET, we have few atlases of normality allowing the realization of objective quantitative analyses. An atlas of normality is a probabilistic atlas of normal FDG uptake from a representative set of brain PET images of healthy subjects. This type of atlas is essential for intra- and inter-individual comparisons.
Accurate quantitative analysis of brain 18F-FDG PET images acquired on a hybrid PET system has been shown to require an institutional normal database for statistical analyzes (Akdemir et al., JNM 2017 and Della Rosa et al Neuroinformatics, 2014).
- Detailed Description
This is a prospective, monocentric, non-randomized study, with no direct individual benefit since it involved healthy volunteers.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 39
- Male or female aged 20 to 50
- Absence of any history or cardiovascular, neurological or psychiatric deficit
- Signed the informed consent
- Contraindication to the realization of an MRI or PET and to the injection of 18F-FDG
- People using a pacemaker or insulin pump
- People wearing a metal prosthesis or an intracerebral clip
- People with intraocular metal splinters
- People with a pathology considered incompatible for the production of the atlas according to the investigator
- Pregnant women and breastfeeding women
- Subject in period of exclusion.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description 18F-FDG injection brain PET-MRI with 18F-FDG Health volunteers with 18-F-FDG injection
- Primary Outcome Measures
Name Time Method Creation, from a representative set of brain PET-MRI images of healthy subjects, of a probabilistic atlas of normal FDG uptake in healthy volunteers 30 minutes after 18F-FDG injection Evaluation of tracer activity at the cerebral level on the acquisition images
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Institut de cancérologie Strasbourg Europe
🇫🇷Strasbourg, France